Wegovy Maker Novo Nordisk Forecasts Sales Decline in 2026

The Danish drugmaker says adjusted sales should decline between 5% and 13% at constant exchange rates this year Novo NordiskNOVO.B-1.41%decrease; red down pointing triangle said it expects lower sales this year as the Danish drugmaker takes stock of lower prices for Ozempic and Wegovy in the U.S. The …